ITMCTR2000002894已完成4 期
Post-market re-assessment for Zhui-Feng Tou-Gu capsule in the treatment of lumbar disc herniation
Temporarily not sure0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational study
入排标准
- 年龄范围
- 18 至 75（—）
- 性别
- All
入选标准
- •(1) Aged 18-75 years;
- •(2) those meeting the diagnostic criteria for lumbar disc herniation.
排除标准
- •(1) Lumbago and leg pain caused by lumbar tuberculosis, lumbar tumor, lumbar canal stenosis, or complete disc herniation and prolapse;
- •(2) patients with bleeding tendency, gastrointestinal bleeding or other chronic hemorrhagic diseases within the past month;
- •(3) women who are pregnant or breast-feeding;
- •(4) allergic constitution or known components of the drug;
- •(5) patients with serious diseases of heart, lung, liver, kidney, hematopoietic system, immune system, etc.
研究者
相似试验
招募中
4 期
Post-marketing reevaluation of Zhuifeng Tougu capsule in treating Rheumatoid ArthritisRheumatoid ArthritisITMCTR2000002895Temporarily not sure
招募中
4 期
Re-evaluation of Zhui-Feng Tou-Gu capsule in the treatment of Osteoarthritis after marketingOsteoarthritisITMCTR2000002898Temporarily not sure
招募中
4 期
Re-evaluation of Zhuifengtougu capsule in the treatment of cervical spondylosisCervical spondylosisITMCTR2000002896Temporarily not sure
招募中
4 期
Re-evaluation of Zhuifengtougu capsule in the treatment of scapulohumeral periarthritisITMCTR2000002897Temporarily not sure
尚未招募
4 期
Post - marketing reevaluation of shengu granule in the treatment of senile osteoporosis.Senile osteoporosisITMCTR2000003182Shanghai Tongji Hospital